Rchr
J-GLOBAL ID:200901001334087179   Update date: Jan. 30, 2024

Okubo Yoshiaki

オオクボ ヨシアキ | Okubo Yoshiaki
Affiliation and department:
Job title: Associate Professor
Research field  (1): Metabolism and endocrinology
Research theme for competitive and other funds  (2):
  • 2007 - 2008 Identification of chemokine receptor in type 1 diabetes and the regulation of the onset
  • 2004 - 2005 T cell epitope of GAD antigen in type 1 diabetes
Papers (23):
  • Heather Torrey, Willem M Kühtreiber, Yoshiaki Okubo, Lisa Tran, Katherine Case, Hui Zheng, Eva Vanamee, Denise L Faustman. A novel TNFR2 agonist antibody expands highly potent regulatory T cells. Science signaling. 2020. 13. 661
  • Yuusuke Watanabe, Yoshifumi Saisho, Jun Inaishi, Kinsei Kou, Akira Yamauchi, Yasuhiko Kanazawa, Yoshiaki Okubo, Mikiya Tokui, Takatoshi Imai, Rie Murakami, et al. Efficacy and safety of once-weekly exenatide after switching from twice-daily exenatide in patients with type 2 diabetes. Journal of diabetes investigation. 2020. 11. 2. 382-388
  • Heather Torrey, John Butterworth, Toshiyuki Mera, Yoshiaki Okubo, Limei Wang, Danielle Baum, Audrey Defusco, Sara Plager, Sarah Warden, Daniel Huang, et al. Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs. Science signaling. 2017. 10. 462
  • Yoshiaki Okubo, Heather Torrey, John Butterworth, Hui Zheng, Denise L Faustman. Treg activation defect in type 1 diabetes: correction with TNFR2 agonism. Clinical & translational immunology. 2016. 5. 1. e56
  • Liqin Ban, Willem Kuhtreiber, John Butterworth, Yoshiaki Okubo, Éva S Vanamee, Denise L Faustman. Strategic internal covalent cross-linking of TNF produces a stable TNF trimer with improved TNFR2 signaling. Molecular and cellular therapies. 2015. 3. 7-7
more...
MISC (5):
  • Yoshifumi Yamada, Kyoko Iwase, Akira Shimada, Yoshiaki Okubo, Yasuhiko Kanazawa, Junichiro Irie, Yoichi Oikawa, Toshihide Kawai, Hiroshi Hirose, Taro Maruyama, et al. FOXP3/Scurfin Gene Polymorphism Is Associated with Female Japanese Type 1 Diabetic Patients. DIABETES. 2009. 58. A590-A590
  • Yasohiko Kanazawa, Youichi Oikawa, Yoshiaki Okubo, Takatoshi Imai, Jyunichi Miyazaki, Akira Shimada, Hiroshi Itoh. Regulatory role of glutamic acid decarboxylase (GAD) reactive T cell in murine model of type 1 diabetes. DIABETES. 2008. 57. A354-A354
  • Kyoko Iwase, Toshihide Kawai, Yasuhiko Kanazawa, Yoshiaki Okubo, Yoichi Oikawa, Taro Maruyama, Akira Shimada, Hiroshi Ito. Foxp3/scurfin gene polymorphism in 'Adult' type 1 diabetes in Japanese. DIABETES. 2007. 56. A288-A288
  • Yoichi Oikawa, Toshikatsu Shigihara, Hiroyuki Yoneyama, Yasuhiko Kanazawa, Yoshiaki Okubo, Kouji Matsushima, Eiji Yamato, Jun-Ichi Miyazaki, Akira Kasuga, Takao Saruta, et al. The role of CXC chemokine ligand 10 in a spontaneous development of autoimmune diabetes in nonobese diabetic mice. DIABETES. 2006. 55. A280-A281
  • Yoshiaki Okubo, Yasuhiko Kanazawa, Yoichi Oikawa, Jun-Ichi Miyazaki, Akira Shimada. Islet hypertrophy observed in "reversed" diabetic NOD mouse after pancreatic beta cell line administration. DIABETES. 2006. 55. A281-A281
Education (1):
  • 1993 - 1999 慶應義塾大学医学部
Professional career (1):
  • MD, PhD (Keio University)
Work history (5):
  • 2022/06 - 現在 東京歯科大学市川総合病院 内科 准教授
  • 2014/04 - 2022/05 東京歯科大学市川総合病院 内科 講師
  • 2011/09 - 2014/03 東京歯科大学市川総合病院 内科 助教
  • 2007/11 - 2011/08 Harvard Medical School, Massachusetts General Hospital Immunobiology Laboratory Research fellow
  • 2003/06 - 2007/03 慶應義塾大学医学部 内科学教室(腎臓内分泌代謝) 助手
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page